Status:
RECRUITING
Self-compassion and Bipolar Disorder
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Bipolar Disorder
Eligibility:
All Genders
18+ years
Brief Summary
Currently, pharmacotherapy is central in the management of bipolar disorder (BD), but does not guarantee satisfactory results for many patients. Existing psychotherapies, notably cognitive-behavioral ...
Eligibility Criteria
Inclusion
- Major subject (≥ 18 years old)
- Subject with diagnosed bipolar disorder followed on an outpatient basis, in a day hospital or outside the hospital during the period from January 1, 2022 to February 29, 2024.
- Absence of written opposition in the subject's medical file to the reuse of their data for scientific research purposes.
Exclusion
- Subject having expressed his opposition to the reuse of his data for scientific research purposes.
- Judicial measures: care under constraint or patient deprived of liberty due to a legal measure
Key Trial Info
Start Date :
June 20 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 20 2025
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06497868
Start Date
June 20 2024
End Date
June 20 2025
Last Update
July 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Psychiatrie - CHU de Strasbourg - France
Strasbourg, Les Hôpitaux Universitaires de Strasbourg, France, 67091